{
  "uuid": "ee644e64-725d-4958-9771-dac665bcc08a",
  "title": "Healthy Returns: The first drug for a common, deadly liver disease is here â€“ and more are coming",
  "description": "Drugmakers are racing to catch up to Madrigal Pharmaceuticals, which has the first drug for NASH liver disease. Meanwhile, AI takes center stage at HIMSS.",
  "keywords": "Biotech and Pharmaceuticals, Health care industry, Merck & Co Inc, Zealand Pharma A/S, Zealand Pharma A/S, Madrigal Pharmaceuticals Inc, Science, United States, Akero Therapeutics Inc, Viking Therapeutics Inc, Aligos Therapeutics Inc, Eli Lilly and Co, Novo Nordisk A/S, Novo Nordisk A/S, 89Bio Inc, Microsoft Corp, Alphabet Inc, GE HealthCare Technologies Inc, Salesforce Inc, business news",
  "snippet": "Think a friend or colleague should be getting this newsletter? Share this link with them to sign up.\n\nGood morning! Millions of Americans with a common and pote...",
  "url": "https://www.cnbc.com/2024/03/19/healthy-returns-first-nash-liver-disease-drug-is-here-more-coming.html",
  "image_url": "https://image.cnbcfm.com/api/v1/image/105649172-1545937328446gettyimages-911340738.jpeg?v=1710452648&w=1920&h=1080",
  "language": "en",
  "published_at": "2024-03-19T14:08:05.000000Z",
  "source": "cnbc.com",
  "categories": [
    "general",
    "business"
  ],
  "relevance_score": null,
  "locale": "us",
  "index": 83
}